Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hongyan Tong

Showing results (31-40 of 208) with videos related to

Pageof 21
Sort By:
Genes, Chromosomes & Cancer|May 12, 2026
Novel Fusion Gene Transcripts and Targetable Mutations in High-Risk B-ALL With Exceptional Response to Venetoclax-Based TherapyJifang Tu, Huanping Wang, Yungui Wang, et al.
Frontiers in Oncology|December 19, 2022
Cerebrospinal fluid interleukin-6 is a potential diagnostic biomarker for central nervous system involvement in adult acute myeloid leukemiaJiayan Gu, Xin Huang, Yi Zhang, et al.
Cancer Medicine|May 6, 2026
Clinical Characteristics, Gene Mutation Profiles and Prognosis of Patients With Acute Myeloid Leukemia Carrying PHF6 MutationsDongmei Wang, Hanzhang Pan, Yungui Wang, et al.
Leukemia & Lymphoma|September 23, 2022
Prognostic effects of clinical parameters, genetic abnormalities, and subtypes in primary gastric diffuse large B-cell lymphoma: a cohort analysis of 146 patientsJunqing Liu, Juying Wei, Xue Jiang, et al.
Plos One|June 18, 2014
Prognostic value of isocitrate dehydrogenase mutations in myelodysplastic syndromes: a retrospective cohort study and meta-analysisJie Jin, Chao Hu, Mengxia Yu, et al.
Biomolecules|January 23, 2024
Harnessing Nanotechnology: Emerging Strategies for Multiple Myeloma TherapyMin Yang, Yu Chen, Li Zhu, et al.
Leukemia Research|September 29, 2012
High efficacy of arsenic trioxide plus all-trans retinoic acid based induction and maintenance therapy in newly diagnosed acute promyelocytic leukemiaYinjun Lou, Wenbin Qian, Haitao Meng, et al.
Molecular and Clinical Oncology|October 4, 2014
Alcohol consumption and risk of myelodysplastic syndromes: A meta-analysis of epidemiological studiesJie Jin, Mengxia Yu, Chao Hu, et al.
Plos One|October 22, 2014
Pesticide exposure as a risk factor for myelodysplastic syndromes: a meta-analysis based on 1,942 cases and 5,359 controlsJie Jin, Mengxia Yu, Chao Hu, et al.
Hematological Oncology|August 22, 2013
Long-term efficacy of low-dose all-trans retinoic acid plus minimal chemotherapy induction followed by the addition of intravenous arsenic trioxide post-remission therapy in newly diagnosed acute promyelocytic leukaemiaYinjun Lou, Wenbin Qian, Haitao Meng, et al.
Pageof 21

Showing results (31-40 of 208) with videos related to

Sort By:
Pageof 21
Genes, Chromosomes & Cancer|May 12, 2026
Novel Fusion Gene Transcripts and Targetable Mutations in High-Risk B-ALL With Exceptional Response to Venetoclax-Based TherapyJifang Tu, Huanping Wang, Yungui Wang, et al.
Frontiers in Oncology|December 19, 2022
Cerebrospinal fluid interleukin-6 is a potential diagnostic biomarker for central nervous system involvement in adult acute myeloid leukemiaJiayan Gu, Xin Huang, Yi Zhang, et al.
Cancer Medicine|May 6, 2026
Clinical Characteristics, Gene Mutation Profiles and Prognosis of Patients With Acute Myeloid Leukemia Carrying PHF6 MutationsDongmei Wang, Hanzhang Pan, Yungui Wang, et al.
Leukemia & Lymphoma|September 23, 2022
Prognostic effects of clinical parameters, genetic abnormalities, and subtypes in primary gastric diffuse large B-cell lymphoma: a cohort analysis of 146 patientsJunqing Liu, Juying Wei, Xue Jiang, et al.
Plos One|June 18, 2014
Prognostic value of isocitrate dehydrogenase mutations in myelodysplastic syndromes: a retrospective cohort study and meta-analysisJie Jin, Chao Hu, Mengxia Yu, et al.
Biomolecules|January 23, 2024
Harnessing Nanotechnology: Emerging Strategies for Multiple Myeloma TherapyMin Yang, Yu Chen, Li Zhu, et al.
Leukemia Research|September 29, 2012
High efficacy of arsenic trioxide plus all-trans retinoic acid based induction and maintenance therapy in newly diagnosed acute promyelocytic leukemiaYinjun Lou, Wenbin Qian, Haitao Meng, et al.
Molecular and Clinical Oncology|October 4, 2014
Alcohol consumption and risk of myelodysplastic syndromes: A meta-analysis of epidemiological studiesJie Jin, Mengxia Yu, Chao Hu, et al.
Plos One|October 22, 2014
Pesticide exposure as a risk factor for myelodysplastic syndromes: a meta-analysis based on 1,942 cases and 5,359 controlsJie Jin, Mengxia Yu, Chao Hu, et al.
Hematological Oncology|August 22, 2013
Long-term efficacy of low-dose all-trans retinoic acid plus minimal chemotherapy induction followed by the addition of intravenous arsenic trioxide post-remission therapy in newly diagnosed acute promyelocytic leukaemiaYinjun Lou, Wenbin Qian, Haitao Meng, et al.
Pageof 21